INIS
tissues
93%
plasma
67%
patients
56%
thrombin
48%
cancer
34%
sensitivity
31%
phospholipids
30%
applications
30%
particles
28%
peaks
28%
comparative evaluations
28%
interference
27%
rabbits
25%
liquids
25%
reagents
25%
atomic force microscopy
25%
blood cells
25%
fibrin
25%
inhibition
25%
resolution
25%
hemostatics
25%
charcoal
25%
wave forms
25%
wavelengths
25%
air
25%
regeneration
25%
ears
25%
balances
25%
endothelium
25%
bones
25%
antibodies
20%
leukemia
20%
anticoagulants
18%
molecules
18%
surfaces
16%
size
16%
coagulants
16%
risks
15%
biological markers
13%
storage
12%
adhesion
12%
proteins
12%
values
10%
apatites
10%
bovine
10%
thrombosis
9%
in vitro
8%
substrates
8%
dilution
7%
control
6%
Keyphrases
Haemostatic Balance
25%
Platelet-rich Fibrin
25%
Bone Regeneration
25%
Vascular Endothelium
25%
Activated Charcoal
25%
Hemostasis Disorders
25%
Extracellular Vesicles
25%
Tissue Characterization
25%
Peak Force
25%
Tapping Mode Atomic Force Microscopy
25%
Promyelocytic
25%
Hypercoagulable State
25%
Tissue Factor Pathway inhibitor-2 (TFPI-2)
25%
Packing Material
25%
Minimum Interference
25%
Optimal Wavelength
25%
Clot Waveform Analysis
25%
Red Cell Concentrates
25%
Middle Ear
25%
Microsurgery
25%
Tapping Mode
20%
Peak Force Tapping
15%
Bovine Hydroxyapatite
10%
Circulating Extracellular Vesicles
7%
Acute Promyelocytic Leukemia Cells
7%
Acute Promyelocytic Leukemia
7%
Disseminated Intravascular Coagulation
7%
Plasma Dilution
5%
Venous Thromboembolism
5%
Lag Time
5%
Viper Venom
5%
Negatively Charged Phospholipids
5%
Impact Target
5%
Cellular Adhesion Molecules
5%
Negatively Charged Tissues
5%
Endothelium Activation
5%
Anticoagulant Property
5%
Procoagulant Factor
5%
Adhesion Molecules Expression
5%
Adhesion Molecules
5%
Protein C Anticoagulant Pathway
5%
Tumourigenesis
5%
Cellular Expression
5%
Anticoagulant Factor
5%
Targeted Review
5%
Heparin-like
5%
Cascading Activation
5%
Coagulates
5%
Tissue Factor Expression
5%
Thrombotic Risk
5%
Medicine and Dentistry
Procoagulant
100%
Thrombin
46%
Thromboplastin
35%
Disseminated Intravascular Coagulation
32%
Biological Marker
27%
Thrombosis
25%
Acute Leukemia
25%
Microparticle
25%
Erythrocyte Concentrate
25%
Tissue Factor Pathway Inhibitor
25%
Platelet-Rich Fibrin
25%
Venous Thromboembolism
22%
Phospholipid
15%
Acute Promyelocytic Leukemia
14%
Erythrocyte
12%
Leukemia Cell
7%
Hematologic Malignancy
6%
Proteoglycan
6%